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Abstract 
 In recent study, the Herbal Anti-atherosclerosis Formulation 
comprising of Lemon, Garlic, Ginger and Apple fruit extract vinegar have 
been generally recognized as agents for prevention and treatment of 
cardiovascular and other metabolic ailments, atherosclerosis, hyperlipidemia, 
thrombosis, hypertension and diabetes and cholesterol bringing down impact. 
Accordingly, the present study was intended to investigate thrombolytic 
properties of Herbal Anti-atherosclerosis Formulation. Natural Anti-
atherosclerosis Formulation of demonstrated exceptionally huge (P <0.001) 
clot lytic properties in different blood samples. The percent clot lytic activity 
was compared with negative control (water) and standard enzyme positive 
control (streptokinase). The mean % of clot lysis for water and streptokinase 
was discovered 4.71% and 86.21% individually. Then again the mean 
percent clot lytic activity of Herbal Anti-atherosclerosis Formulation was 
discovered 29.51%, which is huge contrast and the positive and negative 
control. The present research recommends that Herbal Anti-atherosclerosis 
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Formulation has significant thrombolytic action. Consequently the detailing 
may be a wellspring of powerful natural medication. 
 
Keywords: Thrombolytic activity, Streptokinase, Herbal Anti-
atherosclerosis Formulation  
 
Introduction 
 Herbal medicine is utilized to treat numerous conditions, for 
example, asthma, dermatitis, premenstrual disorder, rheumatoid joint pain, 
headache, menopausal manifestations, unending weariness, fractious inside 
disorder, and growth, among others [1]. In many situations, researchers aren't 
sure what particular ingredient in a specific herb attempts to treat a condition 
or ailment. Entire herbs contain numerous ingredients, and they may 
cooperate to deliver a valuable effect. Frequently, herbs may be utilized 
together on the grounds that the mixture is more effective and may have less 
effects [2] . The point of the present research is to find out the thrombolytic 
effect of Herbal Anti-atherosclerosis Formulation. Therefore the formulation 
may be a source of powerful natural medication. 
 A blood clot (thrombus) produce in the blood circulatory system due 
to the failure of homeostasis reason vascular blockage and while recovering 
leads to serious consequences in atherothrombotic diseases such as acute 
myocardial or cerebral infarction, at times prompting to death. Usually 
utilized thrombolytic agents are alteplase, anistreplase, streptokinase, 
urokinase and tissue plasminogen activator (tPA) to dissolve clots [3]. All 
available thrombolytic agents still have significant shortcomings, including 
the need for large doses to be vast effective, limited fibrin specificity and 
bleeding tendency. In view of the inadequacies comings of the available 
thrombolytic drugs, attempts are in progress to create enhanced recombinant 
variations of these medications [8]. Heparin and Aspirin are just decently 
efficient for acceleration of lysis and prevention of reocclusion, however are 
safe. More particular thrombin inhibitors and antiplatelet agents are more 
powerful, yet their safety stays to be affirmed [4]. Proceeded investigation in 
this area will provide new insights and advance advancement toward the 
improvement of the perfect thrombolytic treatment, characterized by 
maximized stable coronary arterial thrombolysis with minimal bleeding [5].  
 
Materials and Method 
Reagents and chemicals 
 Streptokinase(SK) vials of 15, 00, 000 I.U.10 blood (5ml) sample 
drawn from healthy human volunteers, Herbal antiatherosclerosis 
formulation, Distilled Water. 
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Apparatus 
 Micro centrifuge tube (0.5ml/tube), Micropipette, Vortex mixer, 
0.22-micron syringe filter, Beaker, Electric Balance, Incubator. 
 
Experimental procedure 
Streptokinase (SK) 
 To the commercially available lyophilized SK vial (Durakinase, 
Dongkook Pharma. Co. Ltd. South Korea) of 15, 00,000 I.U., 5 ml sterile 
distilled water was added and mixed properly. This suspension was used as a 
stock from which 100 μl (30,000 I.U.) was used for in vitro thrombolysis. 
 
Specimen 
 Whole blood (4 ml) was drawn from healthy human volunteers (n = 
20) without a history of oral contraceptive or anticoagulant therapy (using a 
protocol approved by the Institutional Ethics Committee of Central India 
Institute of Medical Sciences, Nagpur). 500 μl (0.5 ml) of blood was 
transferred to each of the three previously weighed microcentrifuge tubes to 
form clots. 
 
Herbal preparation 
 100 mg Herbal Antiatherosclerosis formulation was suspended in 10 
ml distilled water and the suspension was shaken vigorously on a vortex 
mixer. The suspension was kept overnight and decanted to remove the 
soluble supernatant, which was filtered through a 0.22-micron syringe filter. 
100µl of this aqueous preparation of herb was added to the microcentrifuge 
tubes containing the clots to check thrombolytic activity [7]. 
 
Clot lysis 
 4 ml venous blood drawn from healthy volunteers was distributed in 
three different pre weighed sterile microcentrifuge tube (0.5 ml/tube) and 
incubated at 37°C for 45 minutes. After clot formation, serum was 
completely removed without disturbing the clot and each tube having clot 
was again weighed to determine the clot weight (clot weight = weight of clot 
containing tube – weight of tube alone). To one microcentrifuge tube 
containing pre-weighed clot, 100 μl of aqueous extract of Herbal Anti-
atherosclerosis Formulation was added. As a positive control, 100 μl of SK 
and as a negative non thrombolytic control, 100 μl of distilled water were 
separately added to the control tubes numbered. All the tubes were then 
incubated at 37°C for 90 minutes and observed for clot lysis. After 
incubation, fluid released was removed and tubes were again weighed to 
observe the difference in weight after clot disruption. Difference obtained in 
weight taken before and after clot lysis was expressed as percentage of clot 
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lysis. The experiment was repeated 20 times with the blood samples of 20 
volunteers [10, 11, 12, 13, 14, and 15]. % Clot lysis == 2nd wt.−3rd wt.×100   
2nd wt.− 1st wt. [15] 
 
Figure 1: Micro centrifuge tubes used in the experiment. 
Result and Observation 
 
Effect of Herbal Anti-atherosclerosis Formulation on in vitro thrombolysis: 
Blood sample 
 
 
% of Clot lysis 
Control (water) Streptokinase Formulation 
1 4.20 87.20 37.22 
2 5.73 85.00 35.22 
3 4.58 86.80 30.24 
4 4.89 87.36 24.31 
5 5.26 84.60 33.41 
6 4.13 85.10 25.26 
7 4.27 84.18 26.31 
8 4.00 86.16 27.34 
9 5.65 85.12 28.66 
10 5.28 86.2 27.22 
Mean 4.706 86.2075 29.519 
Table 1: Comparing the data of % of Clot lysis using SPSS 11.5 
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Group Statistics (Control vs. Streptokinase) 
  
Control, 
Streptokinase N Mean 
Std. 
Deviation 
Std. 
Error 
Mean 
% of Clot lysis Control 10 4.7990 .65113 .20590 
Streptokinase 10 85.7720 1.12211 .35484 
 
Group Statistics (Control vs. Formulation) 
 
Control, 
Streptokinase N Mean 
Std. 
Deviation 
Std. 
Error 
Mean 
% of Clot lysis Control 10 4.7990 .65113 .20590 
Formulation 10 29.5190 4.39455 1.38968 
 
Group Statistics (Formulation vs. Streptokinase) 
 
Control, 
Streptokinase N Mean 
Std. 
Deviation 
Std. 
Error 
Mean 
% of Clot lysis Streptokinase 10 85.7720 1.12211 .35484 
Formulation 10 29.5190 4.39455 1.38968 
 
  Here, all values are expressed as MEAN ± SEM (n=20). 
***P<0.001 significant compared to negative control. 
Effect of Clot lysis 
Sample Result 
Streptokinase (STD) 86.21.56% 
Distilled water (control) 4.71 % 
Sample (Herbal anti-atherosclerosis formulation) 29.51 % 
 
% Clot lysis activity of herbal formulation: 
 
Figure 2: Comparative % in vitro thrombolytic effect of formulation, streptokinase and 
water (negative control). 
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Discussion 
 Addition of 100µl Streptokinase (Durakinase, Dongkook Phama. Co. 
Ltd, South Korea) , a positive control (30,000I.U.) to the clots along with 90 
minutes incubation at 37ºC, showed 86.21% clot lysis. On the other hand, 
clots when treated with 100µl sterile distilled water (negative control) 
showed only negligible clot lysis which was only 4.71%.The mean 
difference in clot lysis percentage between positive and negative control was 
very significant (***p value<0.001).But when 100µl Herbal Anti-
atherosclerosis Formulation was added to 20 different clots, 29.51% clot 
lysis were obtained and when compared  with the negative control(water) the 
mean clot lysis percentage differences was significant (***P 
value<0.001).Percent clot lysis obtained after treating with water, 
streptokinase and Herbal Anti-atherosclerosis Formulation shown in Fig.4.35 
.Statistical representation(Student’s t-test) of the effective clot lysis 
percentage by Herbal anti-atherosclerosis formulation, positive thrombolytic 
control (Streptokinase) and negative control (sterile distilled water) is 
tabulated in Table 4.17. Percentage of clot lysis of 20 different blood 
samples after treated with water, streptokinase and Herbal Anti-
atherosclerosis Formulation is shown in Table. 
 Here, Clot weight = weight of clot containing tube – weight of tube 
alone. 
 All the tubes were incubated at 37ºC for 90 minutes and observe for 
clot lysis. After Incubation fluids released was removed and tubes were again 
weighted to observe the difference in weight after clot disruption. 
Differences obtained in weight taken before and after clot lysis was 
expressed as percentage of clot lysis.    
 
Conclusion 
 Atherosclerosis-induced heart attacks and strokes are leading reasons 
of morbidity and mortality. Current essential and auxiliary prevention 
strategies emphasize control of different atherosclerotic danger components, 
including smoking, hypertension, hypercholesterolemia, diabetes mellitus, 
weight, irritation, and homocysteine [16]. Current pharmacological studies 
recommend remedial estimations of these natural preparations, including 
lowering of blood pressure and lipids, antioxidation, thrombolytic activity 
and the promotion of microcirculation. There is a requirement for more goal 
and scientific approaches to authenticate individual herbs to identify 
chemical constituents, detect adulteration or contamination of herbs, and 
screen the quality of herbs and herbal medicines [17]. There is also a need to 
check the consistency of different batches of herbs utilized as a part of this 
study and to distinguish bioactive parts in herbs reported to have 
physiological effects. 
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 Under this study, Herbal Anti-atherosclerosis Formulation of 
demonstrated very significant (P <0.001) clot lytic properties in different 
blood samples. The percent clot lytic activity was compared with water 
(positive control) and standard enzyme streptokinase (negative control). The 
mean % of clot lysis for water and streptokinase was found 4.71% and 
86.21% separately. Then again the mean percent clot lytic activity of Herbal 
Anti-atherosclerosis Formulation was found 29.51%, which is significant 
compare with the positive and negative control. So, the present research 
proposes that, the Herbal Anti-atherosclerosis Formulation has significant 
thrombolytic activity. Thus the formulation may be a source of effective 
herbal drug. 
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